Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

103.12 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
96 97 Next >
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ: 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
2 Value Stocks With Monster Yields
These two low-priced large-cap stocks sport ginormous yields. 
Via The Motley Fool
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
Via Benzinga
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
Investors are still excited about obesity treatments and weight-management drugs. 
Via The Motley Fool
Are these frigid Dow stocks in for a longer winter?
These three Dow laggards have suffered double-digit percentage declines this winter, contributing to the Dow’s underperformance versus other major averages. 
Via MarketBeat
Topics Economy Stocks
Exposures Economy US Equities
Merck & Company Inc. (NYSE: MRK) Records 52-Week High Monday Morning
Via Investor Brand Network
Beyond The Numbers: 8 Analysts Discuss Merck & Co Stock
Via Benzinga
Merck & Company Inc. (NYSE: MRK) Records 52-Week High Thursday Morning
Via Investor Brand Network
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine... 
Via Benzinga
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. 
Via InvestorPlace
3 companies that more than doubled analyst EPS estimates
Earning season is well underway, and the separation between the winners and losers continues to grow. Of the companies that have beat 
Via MarketBeat
Elanco Animal Health To Offload Aqua Business For $1.3B, Plans To Lower Debt Burden
"Merck Animal Health expands aqua portfolio with the $1.3 billion acquisition of Elanco's aqua business. Expected completion by mid-2024." 
Via Benzinga
Merck Animal Health to Acquire Elanco’s Aqua Business
From Merck & Co., Inc.
Via Business Wire
Merck & Co's Earnings: A Preview
Via Benzinga
Investors should take notice of NYSE:MRK—it offers a great deal for the fundamentals it presents.
Despite its impressive fundamentals, MERCK & CO. INC. (NYSE:MRK) remains undervalued. 
Via Chartmill
7 Mutual Funds That Will Outperform in Any Market
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds. 
Via InvestorPlace
3 Pharma Stocks to Sell in February Before They Crash and Burn
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn. 
Via InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
The Dow led the major indexes higher. Big techs diverged on results. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Investor Optimism Improves Following Earnings, Economic Reports; Dow Jumps Over 350 Points
The CNN Money Fear and Greed index showed an increase in the overall market sentiment, but the index remained in the "Greed" zone on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Merck Stock Rocketed Nearly 5% Skyward Today
The company reported healthy sales growth and proffered encouraging guidance to boot. 
Via The Motley Fool
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a... 
Via Benzinga
Exposures COVID-19
Merck (MRK) Q4 2023 Earnings Call Transcript
MRK earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks Recoup Post-Fed Losses As Traders Challenge Powell, Regional Banks Crack, Gold Rises: What's Driving Markets Thursday?
Wall Street rebounds after Fed meeting with all major indices up, buoyed by earnings & dovish expectations. Probability for March cut at 41%, speculators increase bets for future cuts. Jobless claims... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth
Merck reports fourth quarter 2023 sales of $14.63 billion, a 6% YoY increase, beating estimates. Explore oncology, vaccines, and EPS outlook for 2024. 
Via Benzinga
Nasdaq Futures Rebound As Traders Eye Apple, Meta, Amazon Earnings: Analyst Flags 'January Barometer' That Bodes Well For The Year
After ending January with modest gains, the major averages now look to earnings catalysts to drive momentum, with futures higher in first trading session of February. 
Via Benzinga
Merck Reports A Surprise Profit As Keytruda Sales Continue On Their Warpath
Analysts expected an 11-cent per-share loss from Merck in the fourth quarter. But the company came out ahead. 
Via Investor's Business Daily
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
From Merck & Co., Inc.
Via Business Wire
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
Powell Dubious On March Cut, Markets Slide
Markets pulled back from their steady trading levels today once Fed Chair Jerome Powell, speaking at his press conference following the latest Fed meeting 
Via Talk Markets
Topics Economy
Exposures Interest Rates
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
96 97 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.